New Method for Delivering a Hydrophobic Drug for Photodynamic Therapy Using Pure Nanocrystal Form of the Drug

Overview

Journal Mol Pharm

Publisher American Chemical Society

Specialty Pharmacology

Date 2007 Feb 3

PMID 17266331

Citations 28

Authors

Koichi Baba

Haridas E Pudavar

Indrajit Roy

Tymish Y Ohulchanskyy

Yihui Chen

Ravindra K Pandey

Paras N Prasad

Affiliations

Soon will be listed here.

Abstract

A carrier-free method for delivery of a hydrophobic drug in its pure form, using nanocrystals (nanosized crystals), is proposed. To demonstrate this technique, nanocrystals of a hydrophobic photosensitizing anticancer drug, 2-devinyl-2-(1-hexyloxyethyl)pyropheophorbide (HPPH), have been synthesized using the reprecipitation method. The resulting drug nanocrystals were monodispersed and stable in aqueous dispersion, without the necessity of an additional stabilizer (surfactant). As shown by confocal microscopy, these pure drug nanocrystals were taken up by the cancer cells with high avidity. Though the fluorescence and photodynamic activity of the drug were substantially quenched in the form of nanocrystals in aqueous suspension, both these characteristics were recovered under in vitro and in vivo conditions. This recovery of drug activity and fluorescence is possibly due to the interaction of nanocrystals with serum albumin, resulting in conversion of the drug nanocrystals into the molecular form. This was confirmed by demonstrating similar recovery in presence of fetal bovine serum (FBS) or bovine serum albumin (BSA). Under similar treatment conditions, the HPPH in nanocrystal form or in 1% Tween-80/water formulation showed comparable in vitro and in vivo efficacy.

Citing Articles

Polymeric nanoparticles with a thermoresponsive shell loaded with fluorescent molecules allow for thermally enhanced fluorescence imaging and singlet oxygen generation.

Chepurna O, Yakovliev A, Ziniuk R, Grebinyk A, Xu H, Nikolaeva O Nanoscale Adv. 2025; .

PMID: 39936116 PMC: 11809228. DOI: 10.1039/d4na00687a.

Preparation and Size Control of Efficient and Safe Nanopesticides by Anodic Aluminum Oxide Templates-Assisted Method.

Wang C, Cui B, Wang Y, Wang M, Zeng Z, Gao F Int J Mol Sci. 2021; 22(15).

PMID: 34361113 PMC: 8347391. DOI: 10.3390/ijms22158348.

Self-Assembly Nanoparticles for Overcoming Multidrug Resistance and Imaging-Guided Chemo-Photothermal Synergistic Cancer Therapy.

Gao H, Bai Y, Chen L, Fakhri G, Wang M Int J Nanomedicine. 2020; 15:809-819.

PMID: 32103938 PMC: 7008176. DOI: 10.2147/IJN.S232449.

Core-shell polymeric nanoparticles co-loaded with photosensitizer and organic dye for photodynamic therapy guided by fluorescence imaging in near and short-wave infrared spectral regions.

Chepurna O, Yakovliev A, Ziniuk R, Nikolaeva O, Levchenko S, Xu H J Nanobiotechnology. 2020; 18(1):19.

PMID: 31973717 PMC: 6979398. DOI: 10.1186/s12951-020-0572-1.

Pluronic F-127: An Efficient Delivery Vehicle for 3-(1'-hexyloxy)ethyl-3-devinylpyropheophorbide-a (HPPH or Photochlor).

Cacaccio J, Durrani F, Cheruku R, Borah B, Ethirajan M, Tabaczynski W Photochem Photobiol. 2019; 96(3):625-635.

PMID: 31738460 PMC: 9832393. DOI: 10.1111/php.13183.

References

Roy I, Ohulchanskyy T, Pudavar H, Bergey E, Oseroff A, Morgan J . Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. J Am Chem Soc. 2003; 125(26):7860-5. DOI: 10.1021/ja0343095. View

Chowdhary R, Chansarkar N, Sharif I, Hioka N, Dolphin D . Formulation of benzoporphyrin derivatives in Pluronics. Photochem Photobiol. 2003; 77(3):299-303. DOI: 10.1562/0031-8655(2003)077<0299:fobdip>2.0.co;2. View

Honzak L, Sentjurc M, Swartz H . In vivo EPR of topical delivery of a hydrophilic substance encapsulated in multilamellar liposomes applied to the skin of hairless and normal mice. J Control Release. 2000; 66(2-3):221-8. DOI: 10.1016/s0168-3659(99)00272-2. View

Konan Y, Gurny R, Allemann E . State of the art in the delivery of photosensitizers for photodynamic therapy. J Photochem Photobiol B. 2002; 66(2):89-106. DOI: 10.1016/s1011-1344(01)00267-6. View

Pierre M, Ricci Jr E, Tedesco A, Bentley M . Oleic acid as optimizer of the skin delivery of 5-aminolevulinic acid in photodynamic therapy. Pharm Res. 2005; 23(2):360-6. DOI: 10.1007/s11095-005-9261-x. View

Sobolev A, Rozenkrants A, Giliazova D . [Approaches to the targeted intracellular delivery of photosensitizers in order to enhance their efficacy and cell specificity]. Biofizika. 2004; 49(2):351-79. View

Bellnier D, Greco W, Nava H, Loewen G, Oseroff A, Dougherty T . Mild skin photosensitivity in cancer patients following injection of Photochlor (2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a; HPPH) for photodynamic therapy. Cancer Chemother Pharmacol. 2005; 57(1):40-5. DOI: 10.1007/s00280-005-0015-6. View

Reddy L . Drug delivery to tumours: recent strategies. J Pharm Pharmacol. 2005; 57(10):1231-42. DOI: 10.1211/jpp.57.10.0001. View

Pandey R, Sumlin A, Constantine S, Aoudla M, Potter W, Bellnier D . Alkyl ether analogs of chlorophyll-a derivatives: Part 1. Synthesis, photophysical properties and photodynamic efficacy. Photochem Photobiol. 1996; 64(1):194-204. DOI: 10.1111/j.1751-1097.1996.tb02442.x. View

10.

Korinek M, Dedic R, Svoboda A, Hala J . Luminescence study of singlet oxygen production by meso-tetraphenylporphine. J Fluoresc. 2004; 14(1):71-4. DOI: 10.1023/b:jofl.0000014662.63020.93. View

11.

Fukuda H, Casas A, Batlle A . Use of ALA and ALA derivatives for optimizing ALA-based photodynamic therapy: a review of our experience. J Environ Pathol Toxicol Oncol. 2006; 25(1-2):127-43. DOI: 10.1615/jenvironpatholtoxicoloncol.v25.i1-2.70. View

12.

Bellnier D, Henderson B, Pandey R, Potter W, Dougherty T . Murine pharmacokinetics and antitumor efficacy of the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a. J Photochem Photobiol B. 1993; 20(1):55-61. DOI: 10.1016/1011-1344(93)80131-r. View

13.

Bellnier D, Greco W, Loewen G, Nava H, Oseroff A, Pandey R . Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients. Cancer Res. 2003; 63(8):1806-13. View

14.

Dougherty T . Photodynamic therapy (PDT) of malignant tumors. Crit Rev Oncol Hematol. 1984; 2(2):83-116. DOI: 10.1016/s1040-8428(84)80016-5. View

15.

Kessel D, Woodburn K . Biodistribution of photosensitizing agents. Int J Biochem. 1993; 25(10):1377-83. DOI: 10.1016/0020-711x(93)90685-8. View

16.

LEVY J, Obochi M . New applications in photodynamic therapy. Introduction. Photochem Photobiol. 1996; 64(5):737-9. DOI: 10.1111/j.1751-1097.1996.tb01828.x. View

17.

Macdonald I, Morgan J, Bellnier D, Paszkiewicz G, Whitaker J, Litchfield D . Subcellular localization patterns and their relationship to photodynamic activity of pyropheophorbide-a derivatives. Photochem Photobiol. 1999; 70(5):789-97. View

18.

Pandey R, Zheng G, Lee D, Dougherty T, Smith K . Comparative in vivo sensitizing efficacy of porphyrin and chlorin dimers joined with ester, ether, carbon-carbon or amide bonds. J Mol Recognit. 1996; 9(2):118-22. DOI: 10.1002/(SICI)1099-1352(199603)9:2%3C118::AID-JMR251%3E3.0.CO;2-8. View

19.

Frederiksen P, Jorgensen M, Ogilby P . Two-photon photosensitized production of singlet oxygen. J Am Chem Soc. 2001; 123(6):1215-21. DOI: 10.1021/ja003468a. View

20.

Chowdhary R, Shariff I, Dolphin D . Drug release characteristics of lipid based benzoporphyrin derivative. J Pharm Pharm Sci. 2003; 6(1):13-9. View